Skip to main navigation Skip to search Skip to main content

Cardio-oncology: Capecitabine Can Sometimes be Heatbreaking Capecitabine-Induced Takotsubo Cardiomyopathy Case Report and Literature Review

  • Ramy Abdelmaseih
  • , Anamarys Blanco
  • , Randa Abdelmasih
  • , Krutika Desai
  • , Joshua Pothen
  • , Jay Patel
  • , Rama Balaraman

Research output: Contribution to journalReview articlepeer-review

Abstract

Capecitabine has been more recognized for its cardiotoxicity with an incidence that varies widely. It demonstrates its toxicity in the forms of acute coronary syndrome, arrhythmias and, to a lesser extent, cardiomyopathy. There are several proposed theories including coronary vasospasm, endothelial injury, and oxidative stress. We present a case of capecitabine-induced cardiomyopathy in a patient with pancreatic cancer and mild coronary artery disease, and shed light on other cardio-toxic agents, their proposed mechanism of cardiotoxicity, and on cardiomyopathy in general.

Original languageEnglish (US)
Article number100854
JournalCurrent Problems in Cardiology
Volume46
Issue number8
DOIs
StatePublished - Aug 2021
Externally publishedYes

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Fingerprint

Dive into the research topics of 'Cardio-oncology: Capecitabine Can Sometimes be Heatbreaking Capecitabine-Induced Takotsubo Cardiomyopathy Case Report and Literature Review'. Together they form a unique fingerprint.

Cite this